Home › Gastrointestinal Stromal Tumors › Texas › Dallas
Gastrointestinal Stromal Tumors clinical trials in Dallas, TX
4 studies for Gastrointestinal Stromal Tumors are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
RecruitingPhase 3
- GSK Investigational Site, Dallas
DESTINY-PANTUMOUR04
RecruitingObservational study
- Research Site, Dallas
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RecruitingPhase 2
- Baylor Scott & White Research Institute, Dallas
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
RecruitingPhase 1
- Sarah Cannon Research Institute, Dallas
Gastrointestinal Stromal Tumors trials in other cities
- Miami, FL8 studies
- New York City, NY7 studies
- Boston, MA7 studies
- Philadelphia, PA6 studies
- Houston, TX6 studies
- Nashville, TN5 studies
- Portland, OR5 studies
- San Diego, CA5 studies
- Omaha, NE5 studies
- Rochester, MN4 studies
- Chicago, IL4 studies
- Jacksonville, FL4 studies
Other studies in Dallas
- Breast Cancer55 studies
- Non-Small Cell Lung Cancer52 studies
- Metastatic Cancer42 studies
- Heart Failure42 studies
- Cancer (all types)37 studies
- Prostate Cancer36 studies
- Colorectal Cancer33 studies
- Obesity30 studies
- Ovarian Cancer28 studies
- Lung Cancer27 studies
- Bladder Cancer27 studies
- Endometrial Cancer24 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.